SQZ Biotechnologies Company (SQZB)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 9.79 Million USD | -39.05% |
| 2021 | 16.06 Million USD | -23.48% |
| 2020 | 20.99 Million USD | 4.42% |
| 2019 | 20.1 Million USD | 58.73% |
| 2018 | 12.66 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | -2.07 Million USD | 32.18% |
| 2023 Q1 | -3.05 Million USD | -135.7% |
| 2023 Q3 | -2.22 Million USD | -7.68% |
| 2022 FY | 9.79 Million USD | -39.05% |
| 2022 Q1 | 117 Thousand USD | -98.79% |
| 2022 Q4 | 8.55 Million USD | 1322.63% |
| 2022 Q2 | 527 Thousand USD | 350.43% |
| 2022 Q3 | 601 Thousand USD | 14.04% |
| 2021 Q3 | 4.75 Million USD | 0.0% |
| 2021 FY | 16.06 Million USD | -23.48% |
| 2021 Q4 | 9.63 Million USD | 102.65% |
| 2020 FY | 20.99 Million USD | 4.42% |
| 2019 FY | 20.1 Million USD | 58.73% |
| 2018 FY | 12.66 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 401658.016% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 16.334% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 3165.348% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 91.777% |
| Qrons Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 137.964% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 20394.66% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 7982.432% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 34.702% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -315631.786% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -14800.803% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 28779.356% |
| Mesoblast Limited | -35.16 Million USD | 127.849% |
| Marizyme, Inc. | 457.7 Thousand USD | -2039.82% |
| Genus plc | 178.7 Million USD | 94.519% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 95.55% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -15639.402% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -2287.82% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 89136.364% |
| ContraFect Corporation | -154 Thousand USD | 6459.74% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 19688.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -12659.083% |
| IMV Inc. | -962.29 Thousand USD | 1117.772% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 2627.477% |
| MultiCell Technologies, Inc. | 49.32 USD | -19857969.749% |
| ONE Bio Corp. | 20.12 Million USD | 51.335% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 75.676% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -19928.63% |
| Q BioMed Inc. | -8988.00 USD | 109067.512% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 65.337% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 63598.444% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 77.92% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 957.94% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -13891.429% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 197878.675% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -6870.819% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 10143.583% |
| GB Sciences, Inc. | -624.00 USD | 1569651.282% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 11484.665% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.87% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 4708753.846% |
| Enzolytics Inc. | 30.7 Thousand USD | -31793.969% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -1930.126% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 99.116% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 2003.559% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -1486.371% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 97.609% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 110691.689% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 11780.521% |
| Kadimastem Ltd | -630.13 Thousand USD | 1654.263% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -891.315% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -1.904% |
| BioStem Technologies, Inc. | 15.42 Million USD | 36.505% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 82854.542% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -5447.123% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -5447.123% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -621.663% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 33872.414% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -2076.236% |
| SYBLEU INC | 11.69 Thousand USD | -83638.03% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -112.543% |
| Bioxytran, Inc. | -8285.00 USD | 118313.639% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 2725.737% |
| Neutra Corp. | 14.33 Thousand USD | -68222.288% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 12043.902% |
| PureTech Health plc | -1.6 Million USD | 710.979% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 1078.191% |
| IXICO plc | 3.27 Million USD | -199.511% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 1511.239% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 646.845% |
| CSL Limited | 7.7 Billion USD | 99.873% |
| Cellectis S.A. | 18 Thousand USD | -54311.111% |